Best Online Share/Stock Trading & Investment Broker in India - Mastertrust

Divi`s Laboratories Ltd.

BSE : 132488 NSE : DIVISLAB ISIN : INE361B01024 Industry : Pharmaceuticals & Drugs
5,018.90
Change: 22.95 (0.46 %)
As on 26-Oct-2021 03:58 PM
Prev.Close 4,995.95
Open 4,995.00
Day's High 5,074.00
Day's Low 4,972.10
Mkt.Cap ( Cr.) 133,236.24
Face Value 2.00
PE Ratio 64.77
PB Ratio 10.37

52 Week High Low

Low: 3,020.10
High: 5,425.10
LTP:5,018.90

Lifetime High Low

Low: 452.63
High: 5,425.10
LTP:5,018.90

Divi`s Laboratories Ltd.

BSE : 132488 NSE : DIVISLAB ISIN : INE361B01024 Industry : Pharmaceuticals & Drugs
5,034.80
B S Sip
Change: 38.00 (0.76 %)
As on 26-Oct-2021 04:00 PM
Prev.Close 4,996.80
Open 4,997.00
Day High 5,073.85
Day Low 4,973.40
Mkt.Cap ( Cr. ) 133,658.33
Face Value 2.00
P/E Ratio 64.77
PB Ratio 10.37

52 Week High Low

Low:3,021.95
High:5,425.00
LTP:5,034.80

Lifetime High Low

Low:452.50
High:5,425.00
LTP:5,034.80

P/E Ratio

52 W L(14.96)
52 W H(40.26)

P/E Ratio

52 W L(14.96)
52 W H(40.26)
Had I Invested a sum of 1,00,000 on the same day 5 years ago,the money would have become 392838.13 ( a of 31.47 p.a.)

Key Levels

Support Level 1 4,890.53
Support Level 2 4,785.12
Resistance Level 1 5,085.68
Resistance Level 2 5,175.42

Moving Average

20 Days 5,090.14
50 Days 5,066.74
100 Days 4,813.33
200 Days 4,268.69
Jagsonpal Pharmaceuticals Ltd. 176.40 Change: 17.20 (10.80%)
PE : 16.92
1Y Return: 354.05%

B S
AMI Organics Ltd. 1,105.95 Change: 93.95 (9.28%)
PE : 68.34
1Y Return: 0.00%

B S
Beta Drugs Ltd. 566.45 Change: 44.20 (8.46%)
PE : 42.83
1Y Return: 339.11%

B S
Hikal Ltd. 501.45 Change: 35.95 (7.72%)
PE : 34.35
1Y Return: 192.56%

B S
FY 2021FY 2020FY 2019FY 2018FY 2017
EBDITA Margin (%)42.4337.7841.1235.5537.26
PBT Margin (%)38.6534.1437.5731.7834.14
PAT Margin (%)28.7525.8527.3122.6625.91
ROCE (%)31.6425.2328.0621.3128.27
ROE (%)23.5719.2120.6115.3021.57
FY 2021FY 2020FY 2019FY 2018FY 2017
Total Income ( Cr.)6,861.145,500.435,036.243,928.424,099.79
Gross Profit ( Cr.)2,882.521,999.242,002.041,361.781,511.49
Profit Before Tax ( Cr.)2,627.871,813.291,833.231,219.361,388.23
Tax ( Cr.)673.15440.58500.58349.78334.96
Profit After Tax ( Cr.)1,954.721,372.711,332.65869.581,053.27
NAME DESIGNATION
Murali K Divi Managing Director
N V Ramana Executive Director
Kiran S Divi Whole Time Director & Chief Executive Officer
Madhusudana Rao Divi Whole Time Director - Projects
Ramesh BV Nimmagadda Chairman
G Suresh Kumar Non Executive Independent Director
R Ranga Rao Non Executive Independent Director
KVK Seshavataram Non Executive Independent Director
S Ganapaty Non Executive Independent Director
Sunaina Singh Non Executive Independent Director
K V Chowdary Non Executive Independent Director
M Satish Choudhury Company Secretary & Compliance Officer
Nilima Prasad Divi Whole Time Director - Commercial
Scheme Name AUM% Value(Rs. Cr.) Holding Date
Axis Long Term Equity Fund - Regular Plan - Growth Know More 5.07 1,742.52 30-Sep-2021
SBI Equity Hybrid Fund - Regular Plan - IDCW Know More 3.54 1,679.55 30-Sep-2021
Axis Focused 25 Fund - Regular Plan - Growth Know More 5.50 1,117.56 30-Sep-2021
SBI Blue Chip Fund - Regular Plan - Growth Know More 3.51 1,117.28 30-Sep-2021
Axis Bluechip Fund - Regular Plan - Growth Know More 3.25 1,077.79 30-Sep-2021
Divi’s Laboratories reports 13% rise in Q1 consolidated net profit
Type: NEWS
Date: 09-Aug-2021 12:21 PM
Total consolidated income of the company increased by 14.24% at Rs 1996.61 crore for Q1FY22
Divi`s Lab reports Profit after tax of Rs 5519.70 Mln, in the June 2021 quarter
Type: CORPORATE RESULT
Date: 07-Aug-2021 12:07 PM
--
Divis Lab reports Profit after tax of Rs 4612.40 Mln, in the December 2020 quarter
Type: CORPORATE RESULT
Date: 06-Feb-2021 12:15 PM
--
Divi’s Laboratories gains on the BSE
Type: MOVERS TODAY
Date: 01-Dec-2020 03:18 PM
The company is planning to commence construction at unit-III Andhra Pradesh facility
Divi’s Laboratories to commence construction at unit-III Andhra Pradesh facility
Type: NEWS
Date: 01-Dec-2020 03:01 PM
The operations are likely to commence within 12 to 18 months for 1st phase of the Project
Divis Lab reports Profit after tax of Rs 5133.00 Mln, in the September 2020 quarter
Type: CORPORATE RESULT
Date: 07-Nov-2020 12:35 PM
--